Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Lip, 2010, Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting, Thromb Haemost, 103, 13, 10.1160/TH09-08-0580 Manzano-Fernández, 2008, Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting, Chest, 134, 559, 10.1378/chest.08-0350 Rossini, 2008, Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy, Am J Cardiol, 102, 1618, 10.1016/j.amjcard.2008.08.021 Gao, 2010, Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation, Circ J, 74, 701, 10.1253/circj.CJ-09-0880 Lamberts, 2012, Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study, Circulation, 126, 1185, 10.1161/CIRCULATIONAHA.112.114967 Lamberts, 2013, Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention, J Am Coll Cardiol, 62, 981, 10.1016/j.jacc.2013.05.029 Ruiz-Nodar, 2012, Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?, Circ Cardiovasc Interv, 5, 459, 10.1161/CIRCINTERVENTIONS.112.968792 Mauri, 2007, Stent thrombosis in randomized clinical trials of drug-eluting stents, N Engl J Med, 356, 1020, 10.1056/NEJMoa067731 1993, The GUSTO Investigators. An inter-national randomized trial comparing four thrombolytic strategies for acute myocardial infarction, N Engl J Med, 329, 673, 10.1056/NEJM199309023291001 Rosendaal, 1993, A method to determine the optimal intensity of oral anticoagulant therapy, Thromb Haemost, 69, 236, 10.1055/s-0038-1651587 Ogawa, 2008, Guidelines for pharmacotherapy of atrial fibrillation, Circ J, 72, 1639 Eisenstein, 2007, Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation, JAMA, 297, 159, 10.1001/jama.297.2.joc60179 Menozzi, 2012, Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis, Thromb J, 10, 22, 10.1186/1477-9560-10-22 Hart, 1999, Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis, Ann Intern Med, 131, 492, 10.7326/0003-4819-131-7-199910050-00003 Connolly, 2006, Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial, Lancet, 367, 1903, 10.1016/S0140-6736(06)68845-4 Ruiz-Nodar, 2008, Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation: implications for bleeding risk and prognosis, J Am Coll Cardiol, 51, 818, 10.1016/j.jacc.2007.11.035 Wan, 2008, Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review, Circ Cardiovasc Qual Outcomes, 1, 84, 10.1161/CIRCOUTCOMES.108.796185 Gwon, 2012, Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study, Circulation, 125, 505, 10.1161/CIRCULATIONAHA.111.059022 Valgimigli, 2012, Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial, Circulation, 125, 2015, 10.1161/CIRCULATIONAHA.111.071589 Tada, 2012, Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2, Circ Cardiovasc Interv, 5, 381, 10.1161/CIRCINTERVENTIONS.111.967463 Dewilde, 2013, Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial, Lancet, 381, 1107, 10.1016/S0140-6736(12)62177-1 Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association, Eur Heart J, 33, 2719, 10.1093/eurheartj/ehs253 Shen, 2007, Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation, J Am Coll Cardiol, 50, 309, 10.1016/j.jacc.2007.01.098 Yamaguchi, 2000, Stroke, 31, 817, 10.1161/01.STR.31.4.817 Yasaka, 2001, Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation, Intern Med, 40, 1183, 10.2169/internalmedicine.40.1183 Hori, 2013, Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation, Stroke, 44, 1891, 10.1161/STROKEAHA.113.000990 Hori, 2013, Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment, Circ J, 77, 632, 10.1253/circj.CJ-12-0899